van de Beek, M.
van Steenoven, I.
van der Zande, J. J.
Porcelijn, I.
Barkhof, F.
Stam, C. J.
Raijmakers, P. G. H. M.
Scheltens, P.
Teunissen, C. E.
van der Flier, W. M.
Lemstra, A. W.
Funding for this research was provided by:
ZonMw (733050509)
Article History
Received: 26 November 2020
Accepted: 16 February 2021
First Online: 26 February 2021
Ethics approval and consent to participate
: The local medical ethics committee approved the study, and patients and caregivers gave their written informed consent. The research is performed according to the principles of the Declaration of Helsinki.
: Not applicable
: MvdB, IvS, JvdZ, IP, CS, and PR report no competing interests relevant to the manuscript. FB is supported by the NIHR Biomedical Research Centre at UCLH. CT is a member of the Innogenetics International Advisory Boards of Fujirebio/Innogenetics and Roche. PS has served as a consultant for Wyeth-Elan, Genentech, Danone, and Novartis and received funding for travel from Pfizer, Elan, Janssen, and Danone Research. WvdF performs the contract research for Boehringer Ingelheim. Her research programs have been funded by ZonMW, NWO, EU-FP7, Alzheimer Nederland, CardioVascular Onderzoek Nederland, Stichting Dioraphte, Gieskes-Strijbis fonds, Boehringer Ingelheim, Piramal Neuroimaging, Roche BV, and Janssen Stellar. All funding is paid to her institution. AL has received funding from Stichting Dioraphte and ZonMW Memorabel (project #733050509).